{"id":"https://openalex.org/W3083709461","doi":"https://doi.org/10.1158/1538-7445.am2020-6649","title":"Abstract 6649: Inhibiting adenosine signaling and KRAS enhances the effect of \u03b1-PD-1 therapy in a KRASG12C/TP53R172H/+ pancreatic cancer model","display_name":"Abstract 6649: Inhibiting adenosine signaling and KRAS enhances the effect of \u03b1-PD-1 therapy in a KRASG12C/TP53R172H/+ pancreatic cancer model","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083709461","doi":"https://doi.org/10.1158/1538-7445.am2020-6649","mag":"3083709461"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-6649","doi":"https://doi.org/10.1158/1538-7445.am2020-6649","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-6649","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001373227","display_name":"Thuc M. Le","orcid":"https://orcid.org/0000-0003-2364-9374","observed_orcids":["https://orcid.org/0000-0003-2364-9374"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"THUC LE","raw_affiliation_strings":["1UCLA, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066633792","display_name":"Evan R. Abt","orcid":"https://orcid.org/0000-0002-3160-7134","observed_orcids":["https://orcid.org/0000-0002-3160-7134"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evan Abt","raw_affiliation_strings":["1UCLA, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101520419","display_name":"Woosuk Kim","orcid":"https://orcid.org/0000-0003-4752-2810","observed_orcids":["https://orcid.org/0000-0003-4752-2810"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Woosuk Kim","raw_affiliation_strings":["1UCLA, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059608519","display_name":"Akshata R. Udyavar","orcid":"https://orcid.org/0000-0002-4563-2365","observed_orcids":["https://orcid.org/0000-0002-4563-2365"]},"institutions":[{"id":"https://openalex.org/I4405269550","display_name":"Arcus Biosciences (United States)","ror":"https://ror.org/04gs0mk80","country_code":"US","type":"company","lineage":["https://openalex.org/I4405269550"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Akshata Udyavar","raw_affiliation_strings":["2Arcus Biosciences, Hayward, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Arcus Biosciences, Hayward, CA","institution_ids":["https://openalex.org/I4405269550"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071926090","display_name":"Arthur Eung-Hyuck Cho","orcid":"https://orcid.org/0000-0001-8670-2473","observed_orcids":["https://orcid.org/0000-0001-8670-2473"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arthur Cho","raw_affiliation_strings":["1UCLA, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112379939","display_name":"Joe Capri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joe Capri","raw_affiliation_strings":["1UCLA, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101499487","display_name":"Jing Cui","orcid":"https://orcid.org/0000-0002-1496-1828","observed_orcids":["https://orcid.org/0000-0002-1496-1828"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jing Cui","raw_affiliation_strings":["1UCLA, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036481001","display_name":"Razmik Ghukasyan","orcid":"https://orcid.org/0000-0003-1795-1892","observed_orcids":["https://orcid.org/0000-0003-1795-1892"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Razmik Ghukasyan","raw_affiliation_strings":["1UCLA, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043782637","display_name":"Luyi Li","orcid":"https://orcid.org/0000-0001-6096-6403","observed_orcids":["https://orcid.org/0000-0001-6096-6403"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luyi Li","raw_affiliation_strings":["1UCLA, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015204240","display_name":"Daniel M. DiRenzo","orcid":"https://orcid.org/0000-0002-2610-353X","observed_orcids":["https://orcid.org/0000-0002-2610-353X"]},"institutions":[{"id":"https://openalex.org/I4405269550","display_name":"Arcus Biosciences (United States)","ror":"https://ror.org/04gs0mk80","country_code":"US","type":"company","lineage":["https://openalex.org/I4405269550"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel DiRenzo","raw_affiliation_strings":["2Arcus Biosciences, Hayward, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Arcus Biosciences, Hayward, CA","institution_ids":["https://openalex.org/I4405269550"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061634527","display_name":"Brandon R. Rosen","orcid":"https://orcid.org/0000-0002-0790-6433","observed_orcids":["https://orcid.org/0000-0002-0790-6433"]},"institutions":[{"id":"https://openalex.org/I4405269550","display_name":"Arcus Biosciences (United States)","ror":"https://ror.org/04gs0mk80","country_code":"US","type":"company","lineage":["https://openalex.org/I4405269550"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brandon Rosen","raw_affiliation_strings":["2Arcus Biosciences, Hayward, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Arcus Biosciences, Hayward, CA","institution_ids":["https://openalex.org/I4405269550"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058851560","display_name":"Timothy R. Donahue","orcid":"https://orcid.org/0000-0002-1175-2545","observed_orcids":["https://orcid.org/0000-0002-1175-2545"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy Donahue","raw_affiliation_strings":["1UCLA, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112267083","display_name":"Matt J. Walters","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405269550","display_name":"Arcus Biosciences (United States)","ror":"https://ror.org/04gs0mk80","country_code":"US","type":"company","lineage":["https://openalex.org/I4405269550"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matt Walters","raw_affiliation_strings":["2Arcus Biosciences, Hayward, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Arcus Biosciences, Hayward, CA","institution_ids":["https://openalex.org/I4405269550"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018755772","display_name":"Caius G. Radu","orcid":"https://orcid.org/0000-0002-9338-5397","observed_orcids":["https://orcid.org/0000-0002-9338-5397"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caius Radu","raw_affiliation_strings":["1UCLA, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"6649","last_page":"6649"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adenosine-signaling","display_name":"adenosine signaling","score":0.9660000205039978},{"id":"https://openalex.org/keywords/cd73","display_name":"CD73","score":0.796999990940094},{"id":"https://openalex.org/keywords/kras-g12c","display_name":"KRAS G12C","score":0.8700000047683716},{"id":"https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma","display_name":"pancreatic ductal adenocarcinoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.8960000276565552},{"id":"https://openalex.org/keywords/cd73-inhibitors","display_name":"CD73 inhibitors","score":0.6449999809265137},{"id":"https://openalex.org/keywords/kras-inhibition","display_name":"KRAS inhibition","score":0.7089999914169312},{"id":"https://openalex.org/keywords/tumor-immunogenicity","display_name":"tumor immunogenicity","score":0.8259999752044678},{"id":"https://openalex.org/keywords/immunosuppressive-tumor-microenvironment","display_name":"immunosuppressive tumor microenvironment","score":0.8960000276565552},{"id":"https://openalex.org/keywords/tumor-metabolism","display_name":"cancer metabolism","score":0.453000009059906},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6759999990463257},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.41200000047683716}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.8991844654083252},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7274566888809204},{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.6261219382286072},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.5981579422950745},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5317422747612},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5091122984886169},{"id":"https://openalex.org/C67907053","wikidata":"https://www.wikidata.org/wiki/Q356147","display_name":"Adenosine receptor","level":4,"score":0.4251860976219177},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.4241117238998413},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.388452410697937},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3170720338821411},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.21211931109428406},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.13463306427001953}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-6649","doi":"https://doi.org/10.1158/1538-7445.am2020-6649","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-6649","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3012992285","https://openalex.org/W7223158931","https://openalex.org/W4362595540","https://openalex.org/W7135342151","https://openalex.org/W4367602627","https://openalex.org/W7214338291","https://openalex.org/W4206803897","https://openalex.org/W2954036842","https://openalex.org/W4401344703","https://openalex.org/W4409631247"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"High":[2],"levels":[3,338],"of":[4,26,35,43,93,104,237,244,287,289,303,324,339,401,413,417],"adenosine":[5,38,291,349,394],"(ADO)":[6],"in":[7,23,63,107,112,175,204,221,250,254,293,306,404],"the":[8,24,32,91,108,240,274,281,284,322,399,414,418],"tumor":[9,105,231,256,265],"microenvironment":[10],"have":[11],"been":[12],"shown":[13],"to":[14,89,99,260,336],"suppress":[15],"immune":[16],"responses":[17],"and":[18,124,165,184,201,216,321,348,357,396,428],"curtail":[19],"T":[20],"cell":[21],"activation":[22],"presence":[25],"anti-PD-1/PD-L1":[27],"blocking":[28],"antibodies.":[29],"CD73":[30,59,74,101,200,246],"catalyzes":[31],"extracellular":[33],"generation":[34],"ADO":[36,80,215],"from":[37,48],"monophosphate":[39],"(AMP).":[40],"KRAS":[41,117,129,193,212,219,305,329,347,360,397],"mutations,":[42],"which":[44,61],"60%":[45],"were":[46,54,87,119,131,146,186,271],"derived":[47],"pancreatic":[49,238,294,307,355,407],"ductal":[50],"adenocarcinoma":[51],"(PDAC)":[52],"samples,":[53],"associated":[55],"with":[56,229,248,273],"significantly":[57],"upregulated":[58,320],"expression,":[60],"resulted":[62,253],"a":[64,78,176,234,245,405],"worsening":[65],"prognosis.":[66],"These":[67,278,341],"immunosuppressive":[68,290,325],"effects":[69],"can":[70],"be":[71],"counteracted":[72],"by":[73,77,116,121,128,133,188],"inhibitors":[75],"or":[76],"dual":[79],"receptor":[81],"(A2aR/A2bR)":[82],"antagonist.":[83],"Method:":[84],"Linear":[85],"models":[86,223,309],"used":[88],"evaluate":[90],"ability":[92],"299":[94],"pan-cancer":[95],"consensus":[96],"oncogenic":[97],"drivers":[98],"predict":[100],"expression":[102,114,203,226,323],"independent":[103],"type":[106],"TCGA":[109],"dataset.":[110],"Changes":[111],"gene":[113,225],"induced":[115,127,224],"inhibition":[118,130,194,213,220,262,302,330],"determined":[120,132],"RNAseq.":[122],"Metabolic":[123,208],"proteomic":[125],"alterations":[126],"LC-MS.":[134],"C57BL/6J":[135],"mice":[136,270],"bearing":[137],"established":[138,251],"KP4662-G12C":[139],"(KRASG12C/TP53R172H/+)":[140],"tumors":[141,252],"(at":[142],"least":[143],"150":[144],"mm3)":[145],"treated":[147,272],"as":[148],"indicated:":[149],"A1421":[150],"(CD73i;":[151],"30":[152],"mg/kg/day,":[153,169],"s.c.),":[154],"anti-PD1":[155],"(Clone":[156],"RMP":[157],"1-14;":[158],"10":[159],"mg/kg;":[160],"twice":[161],"per":[162],"week,":[163],"i.p),":[164],"MRTX-1257":[166,185],"(KRASi,":[167],"100":[168],"p.o.).":[170],"Treatment":[171],"efficacy":[172],"was":[173,267],"monitored":[174],"blinded":[177],"manner":[178],"using":[179],"micro-computed":[180],"tomography":[181],"(mCT).":[182],"A1412":[183],"provided":[187],"Arcus":[189],"Biosciences.":[190],"Data:":[191],"Direct":[192],"reduced":[195],"but":[196],"did":[197],"not":[198],"abolish":[199],"A2aR/A2bR":[202],"multiple":[205],"PDAC":[206,222],"models.":[207],"analyses":[209],"indicated":[210],"that":[211,300,344],"increased":[214,230],"AMP":[217],"levels.":[218],"changes":[227],"consistent":[228],"immunogenicity.":[232],"In":[233],"murine":[235],"model":[236,409],"cancer-bearing":[239],"KRASG12C":[241,261],"mutation,":[242],"co-administration":[243],"inhibitor":[247],"anti-PD-1":[249],"significant":[255],"growth":[257],"retardation,":[258],"comparable":[259],"alone.":[263],"Durable":[264],"regression":[266],"observed":[268],"when":[269],"triple":[275],"combination":[276],"therapy.":[277],"data":[279],"support":[280],"rationale":[282],"for":[283,421],"clinical":[285],"development":[286],"modulators":[288],"signaling":[292,350,395],"cancer.":[295],"Conclusion:":[296],"Here,":[297],"we":[298],"show":[299],"direct":[301],"mutant":[304,346],"cancer":[308,356,408],"yields":[310],"complex":[311],"immunomodulatory":[312],"effects.":[313],"While":[314],"antigen":[315],"presentation":[316],"pathways":[317],"are":[318],"transcriptionally":[319],"chemokine":[326],"is":[327],"reduced,":[328],"also":[331],"reprograms":[332],"nucleotide":[333],"metabolism":[334],"leading":[335],"elevated":[337],"ADO.":[340],"findings":[342],"suggest":[343],"co-targeting":[345],"may":[351],"enhance":[352],"immunotherapy":[353],"against":[354],"potentially":[358],"other":[359],"driven":[361],"malignancies.":[362],"Citation":[363],"Format:":[364],"THUC":[365],"LE,":[366],"Evan":[367],"Abt,":[368],"Woosuk":[369],"Kim,":[370],"Akshata":[371],"Udyavar,":[372],"Arthur":[373],"Cho,":[374],"Joe":[375],"Capri,":[376],"Jing":[377],"Cui,":[378],"Razmik":[379],"Ghukasyan,":[380],"Luyi":[381],"Li,":[382],"Daniel":[383],"DiRenzo,":[384],"Brandon":[385],"Rosen,":[386],"Timothy":[387],"Donahue,":[388],"Matt":[389],"Walters,":[390],"Caius":[391],"Radu.":[392],"Inhibiting":[393],"enhances":[398],"effect":[400],"\u03b1-PD-1":[402],"therapy":[403],"KRASG12C/TP53R172H/+":[406],"[abstract].":[410],"In:":[411],"Proceedings":[412],"Annual":[415],"Meeting":[416],"American":[419],"Association":[420],"Cancer":[422,434],"Research":[423],"2020;":[424],"2020":[425],"Apr":[426],"27-28":[427],"Jun":[429],"22-24.":[430],"Philadelphia":[431],"(PA):":[432],"AACR;":[433],"Res":[435],"2020;80(16":[436],"Suppl):Abstract":[437],"nr":[438],"6649.":[439]},"counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-09-23T05:00:35.095934","created_date":"2020-09-11T00:00:00"}